Answers are grounded in this paper and cite their sources.
To the Editor—We read with interest Richardson and colleagues’ study among primary care patients who received influenza vaccine at Veteran Health Administration (VHA) medical centers from 2010 through 2011 [1]. The authors reported that the high-dose vaccine was not more effective in protecting against hospitalization for influenza or pneumonia, except in the subgroup aged ≥85 years. Three effectiveness studies of Fluzone high-dose vaccine have been published. The prospective, randomized, controlled trial by DiazGranados et al [2] found high-dose vaccine was 24.2% more efficacious than standard-dose vaccine in preventing laboratory-confirmed influenza (19.7% and 32.5%, respectively, for participants aged 65–74 years and ≥75 years [3]). Izurieta et al [4] identified Medicare beneficiaries vaccinated in community pharmacies offering both vaccines who then experienced influenza infection or hospital admission and found high-dose vaccine to be 22% more effective in prevention of both probable influenza infections and influenza-related hospital admissions. With 2 studies with nearly identical results and 1 with sharply different results, what are we to think?
No takes yet. Share an insight, caveat, or question.
Decker et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: